IHE Pharmacy meeting February 7th

Skip to first unread message

Jose Costa Teixeira

Feb 4, 2023, 2:32:25 AM2/4/23
to ihe-pharmacy
Dear Colleagues

For our call this Tuesday, I propose the following agenda:

Now that the Supply profiles are entering the final review phase, I would like to consider starting the next profiles - which I believe are Prescription and Medication Lists. 
Related to this, I suggest we focus on capacity: For Supply we had a bottleneck on technical editors and I would like IHE Pharmacy to have more active editors for the next work items.
We also have some technical change proposals to welcome, and the confirmation and agenda for the F2F meeting in Den Haag.
Finally, we should have a planning discussion for IHE Pharmacy about the current opportunities and how we can take them. Nictiz colleagues are very engaged and could drive that discussion.

Please let me know what you think of the agenda and looking forward to seeing you there.

Kind regards


Jürgen Brandstätter

Feb 5, 2023, 6:45:23 AM2/5/23
to ihe-ph...@googlegroups.com

Dear colleagues,


I have 2 topics, which I would need to discuss in the call:


1) Recent discussion on the “pharm:” namespace (IHE vs HL7): there is a proposal on how to deal with it, needs short explanation and confirmation (Jürgen)



2) A potential new Gemini project on the eP/eD process (“true FHIR”) out of a real-world project in Austria (Jürgen)

About 10min


Jose, if we could find a place for that it would be great!




You received this message because you are subscribed to the Google Groups "IHE Pharmacy" group.
To unsubscribe from this group and stop receiving emails from it, send an email to ihe-pharmacy...@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/ihe-pharmacy/CAMJtjTb4a361AkZwEnDo4GQfb-RWUTtvcJg06WctZwFRjHiDjQ%40mail.gmail.com.

Jose Costa Teixeira

Feb 5, 2023, 7:23:44 AM2/5/23
to ihe-ph...@googlegroups.com
Thank you Juergen

The ePrescription work item is already in the agenda as well as the change proposal.
Looking forward to the discussion.

Kind regards


Reply all
Reply to author
0 new messages